23andMe consumer genetic testing – a challenge to the insurance industry?

12 Jul 2016

In autumn 2014 the US based direct to consumer (DTC) genetic testing company 23andMe, an industry leader in this field, received regulatory approval for marketing their personal genetic testing services to UK and Canadian consumers. Backed by Google, the firm offers personal screening to test for inherited genetic risk factors associated with diseases such as cancer and Alzheimer’s. Their stated claim to customers is to help them better understand how their genes may affect their health and to take informed and proactive health decisions.

Download full article (PDF 224 KB)

We use cookies to gather information that will help us provide the best possible service. By using this site, you are accepting our cookie policy.

In our ongoing efforts to improve the quality and relevance of our publications, we would like to know more about you.

* required fields

Interested in subscribing to our content? Visit our subscription page.